Goldman Pharmaceuticals Private Limited
About Goldman Pharmaceuticals Private Limited
Data last updated:
Goldman Pharmaceuticals Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It was incorporated on 09 August 2024.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U47720UP2024PTC207681.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹50,000. It is led by directors Balraj Chauhan and Sheetal.
Its last annual general meeting (AGM) was held on 01 November 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 154 S – 1 Shalimar Garden Extn – 2 Ghaziabad, Uttar Pradesh, India – 201005.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.77 Lakh. For the same year it recorded a net loss of ₹18,966 (net margin -10.7%) and EBITDA of -₹9,483 (EBITDA margin -5.4%).
Company details
Contact details
Goldman Pharmaceuticals Private Limited's registered office is in Ghaziabad, Uttar Pradesh.
- Registered AddressC – 154 S – 1 Shalimar Garden Extn – 2 Ghaziabad, Uttar Pradesh, India – 201005
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Goldman Pharmaceuticals Private Limited
FY 2025 filings availableGoldman Pharmaceuticals Private Limited reported revenue of ₹1.77 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹9,483 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹18,966 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | -5.4% |
| Net Profit Margin | -10.7% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Goldman Pharmaceuticals Private Limited, buy the company report.
Board of directors of Goldman Pharmaceuticals Private Limited
Goldman Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Balraj Chauhan | Director | 09 Aug 2024 | 2 Years 3 Months | Current |
| Sheetal | Director | 09 Aug 2024 | 2 Years 3 Months | Current |
Peer comparison
Goldman Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Steadmed Pharmaceuticals Private Limited | ₹1.78 Lakh (FY 2024) | 153.0% | Kanpur, Uttar Pradesh, India | |||
| Strikar Pharmaceuticals Private Limited | ₹1.78 Lakh (FY 2019) | Hyderabad, Telangana, India | ||||
| Sirois Pharmaceuticals Private Limited | ₹1.78 Lakh (FY 2024) | 2540843.0% | Dehradun, Uttarakhand, India | |||
| Hartwin Pharmaceuticals Private Limited | ₹1.78 Lakh (FY 2025) | -28.0% | Ghaziabad, Uttar Pradesh, India | |||
| Airiza Pharmaceuticals Private Limited | ₹1.77 Lakh (FY 2022) | -17.0% | Asansol, West Bengal, India | |||
| Goldman Pharmaceuticals Private Limitedthis company | ₹1.77 Lakh (FY 2025) | -₹18,966 | -10.7% | Ghaziabad, Uttar Pradesh, India | ||
| Echomet Pharmaceuticals Private Limited | ₹1.77 Lakh (FY 2025) | Ranchi, Jharkhand, India | ||||
| Proxima Pharmaceuticals Marketing Private Limited | ₹1.76 Lakh (FY 2020) | 11.0% | Bhopal, Madhya Pradesh, India | |||
| Brinj Pharmaceuticals Private Limited | ₹1.76 Lakh (FY 2025) | -40.0% | Shivpuri, Patna, Bihar, India | |||
| Mexicare India Pharmaceuticals Private Limited | ₹1.76 Lakh (FY 2016) | Thiruvananthapuram, Kerala, India | ||||
| Omkam Pharmaceuticals Private Limited | ₹1.75 Lakh (FY 2025) | -26.0% | New Delhi, Delhi, India |
To see the full peer comparison of Goldman Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Goldman Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Goldman Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Goldman Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Goldman Pharmaceuticals Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Balraj Chauhan was appointed as Director on 09 Aug 2024.
Frequently asked questions
Goldman Pharmaceuticals is an active private limited company based in Ghaziabad, Uttar Pradesh, India. It was incorporated on 09 August 2024 (2+ years old) and is registered under CIN U47720UP2024PTC207681.
Goldman Pharmaceuticals has 2 current directors:
- Balraj Chauhan - Director
- Sheetal - Director
The latest financial statements of Goldman Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 01 November 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Goldman Pharmaceuticals is U47720UP2024PTC207681. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Goldman Pharmaceuticals was incorporated on 09 August 2024, making it 2+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Goldman Pharmaceuticals by revenue are Steadmed Pharmaceuticals Private Limited, Strikar Pharmaceuticals Private Limited, Sirois Pharmaceuticals Private Limited, Hartwin Pharmaceuticals Private Limited, Airiza Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Balraj Chauhan was appointed as Director on 09 Aug 2024. Sheetal was appointed as Director on 09 Aug 2024.
The registered office of Goldman Pharmaceuticals is at C – 154 S – 1 Shalimar Garden Extn – 2 Ghaziabad, Uttar Pradesh, India – 201005.
Goldman Pharmaceuticals can be reached at its registered office: C – 154 S – 1 Shalimar Garden Extn – 2 Ghaziabad, Uttar Pradesh, India – 201005.
Goldman Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Uttar Pradesh.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
